Quick Summary TreeFrog Therapeutics announced preclinical data for TFG‑001, a 3D neural microtissue therapy for Parkinson’s disease. The approach aims to replace damaged dopamine‑producing neurons. Preclinical models showed rapid dopamine release, nerve regrowth, and motor recovery. However, the work is still preclinical; a Clinical Trial Application is expected in 2027.
Quick Read Summary Stem Cell Therapy For Autism: What Science Shows and What Remains Experimental Stem cell therapy for autism is still considered experimental treatment. Early clinical trial studies show possible improvements in speech, focus, and social interaction in some children. However, the evidence base remains limited, and doctors do
Quick Read Summary Research Findings Clinical trial studies report some improvement in muscle tone, balance, and walking ability. Researchers study different stem cell types, including umbilical cord blood and bone marrow. Small groups and varied methods cause inconsistent results, so further research is needed. Key Points for Families Stem cell
